Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide in Hemodialysis
NCT04622709Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Oct 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of furosemide in kidney failure (ESRD), sponsored by University of North Carolina at Chapel Hill. Started Oct 2020; status: completed.
02
Drugs
furosemide
03
Conditions
kidney failure (ESRD)
Beyond the preview
Go deeper on NCT04622709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04622709.